Apoptosis in the skin of patients with autoimmune connective tissue disorders

Central-European Journal of Immunology

Volumn 26, Issue 2, 2001, Pages 53-58

  Waszczykowska, Elzbieta ^a   Sysa Jȩdrzejowska, Anna ^a   Dziankowska Bartkowiak, Bozena ^a   Narbutt, Joanna ^a   Pagounis, Christos ^a   Majewski, Slawomir ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis; Interleukin 6; Squamous cell carcinoma; Systemic lupus erythematosus; Systemic sclerosis; Tumor necrosis factor alpha

Indexed keywords

DNA FRAGMENT;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MONONUCLEAR CELL; PIGMENTED NEVUS; SKIN BIOPSY; SKIN GLAND; SQUAMOUS CELL CARCINOMA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE ACTIVATION;

EID: 0035723977     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Apoptosis in peripheral lymphocytes in systemic lupus erythematosus: A review
2. Apoptosis: Clinical relevance and pharmacological manipulation
3. Defective expression of CD95 (Fas/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals
4. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
5. Apoptosis in the rheumatic diseases
6. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
7. Apoptosis and cutaneous biology
8. Mutation at murine motheaten locus are within the hematopoietic cell proteintyrosine phosphatase (Heph) gene
9. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
10. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene
11. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic erythematosus
12. A problem of defective apoptosis
13. TNF-α and cancer therapy - Induced apoptosis: Potentiation by inhibition of NF-κB
14. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
15. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
16. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus
17. Fas ligand-induced apoptosis as a mechanism of immune privilege
18. Physiology of Fas-induced programmed cell death
19. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor α 1
20. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus
21. Fas antigen expression on synovial cells was downregulated by interleukin 1
22. The 1982 revised criteria for the classification of systemic lupus erythematosus
23. Oxidative stress as a mediator of apoptosis
24. Lymphocyte apoptosis induced by CD 95 (APO-1/Fas) ligand - Expressing tumor cells - A mechanism of immune evasion?
25. An essential role for NF-κB in preventing TNF α - Induced cell death
26. Estimation of SLE activity based on the serum level of chosen cytokines and supraoxide radical generation
27. Looking beneath the surface: The cell death pathway of Fas/APO-1 (CD 95)
28. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus
29. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes
30. Profiles of cytokines (TNF-α and IL-6) and acute fase proteins (CRD and α 1 AG) related to the disease course in patients with systemic lupus erythematosus
31. Apoptosis in rheumatoid arthritis. II. p53 overexpression in rheumatoid arthritis synovium
32. Activation of the transcription nuclear factor-κB in human inflamed synovial tissue
33. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes
34. 8-Hydroksydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus
35. Apoptosis in rheumatoid arthritis synovium
36. Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis
37. Localization of apoptosis and expression of apoptosis-related proteins in the synovium of patients with rheumatoid arthritis
38. Bcl-2 family in salivary gland from Sjogren's syndrome: Bax may be involved in the destruction of SS salivary glandular epithelium
39. Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren's syndrome
40. Expression of ductal Fas antigen in sialoafdenitis of Sjogren's syndrome
41. TCR in Fas-sensitive T cells from labial salivary glands of patients with Sjogren's syndrome
42. Endothelial cell apoptosis in a primary pathogenic event underlying skin lesions in avian and human scleroderma